Diagnostics companies to develop new early lung cancer detection technology
This article was originally published in Clinica
Executive Summary
NeoPath, developer of the AutoPap automated Pap smear screening technology, is to team up with Bayer Diagnostics to develop a new automated screening system for lung cancer. The technology will bring together NeoPath's visual intelligence technology with Bayer's molecular probes.